Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s PM Ponders Ways To Encourage Innovative Drug Work

This article was originally published in PharmAsia News

Executive Summary

India's prime minister is considering a proposal for the government to support the kind of medical research the pharmaceutical industry finds too expensive and risky to undertake. The proposal is part of a package of regulatory reforms being studied to encourage drug discovery, support clinical trials and provide approvals of products at different stages of development. The package is part of a $2 billion drug research funding plan that emerged from a series of meetings with drug makers to identify roadblocks that stand in the way of innovative drugs. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts